RxDoctor Payments Data

Krista Knies

Family · Jasper, INNPI 1306506753

Payments from drug & device makers

$387in general payments, 2019–2025

Across 17 payments — averaging $22.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$119
  • Edwards Lifesciences$71
  • Boehringer Ingelheim$54
  • Novo Nordisk$41
  • Astellas Pharma US Inc$17
  • AstraZeneca$16
  • plus $70 from 5 others

What the payments were for

  • Food & beverage$387100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$387 in reported general payments places this provider in the 50th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$52,058
Medicare patients
334
Services billed
913

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban143$131,110
EntrestoSacubitril/Valsartan53$49,031
JardianceEmpagliflozin21$14,926
Repatha SureclickEvolocumab15$11,998
Metoprolol Succinate200$2,336
Diltiazem 24hr Er (Cd)Diltiazem Hcl67$1,529
Atorvastatin Calcium187$1,374
Flecainide Acetate23$1,206
Losartan Potassium109$1,206
Ranolazine ErRanolazine11$1,036
Lisinopril138$1,028
Carvedilol146$854
Furosemide134$686
ClopidogrelClopidogrel Bisulfate53$667
Amlodipine Besylate168$643

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$131,110143 claims
NovartisEntresto$15$49,03153 claims
Boehringer IngelheimJardiance$54$14,92621 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,392 family providers in Indiana.

Other family in Jasper

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →